At Global View Investment Advisors, we believe that successful investing requires a clear view of our current location and the implications for the path forward. While Morningstar stars provide a useful starting point for screening, they shouldn't be the ending point. Unfortunately, many investors navigate their portfolios by looking exclusively in the rearview mirror, guided by the ubiquitous Morningstar Star Rating.
Morningstar Star Ratings are one of the most widely recognized fund rating systems in the investment industry. Funds receive between one and five stars based on their historical risk-adjusted performance relative to similar funds in the same category, with higher ratings reflecting stronger risk-adjusted returns compared to peers over past time periods.
While a 5-star rating is often used as a seal of approval in marketing materials, it is important to remember that these stars are a purely quantitative, backward-looking measure. They tell you how funds performed in the past, but they offer zero insight into how it will perform tomorrow. It is quite possible that a high star rating may point to poorer returns ahead!
The Morningstar system ranks funds on a strict bell curve within specific categories, based upon past performance. Only the top 10% receive 5 stars, while the bottom 10% receive 1 star. This creates several mechanical problems for the average investor:
(Global View is NOT an investor in either fund—we are simply using the funds to illustrate our message. Global View is not affiliated with either fund, and Global View receives no compensation from them.)
To see these flaws in action, we can look at two funds currently sitting in the Foreign Small/Mid Growth category. On paper, they are peers; however, this comparison could not be further from the truth.
In 2018, the Brown Capital Management International Small Company Fund (BCSVX) held a 5-star Morningstar rating, reflecting strong prior risk-adjusted performance relative to its peers at the time. However, in the following years, the fund experienced periods of significant volatility due to its heavy concentration in hyper-growth tech and healthcare.
A probable misleading comparison from the Star Rating system is BCSVX to the American Beacon IMC International Small Cap Fund (TOVYX). TOVYX is also classified within the same Morningstar category; however, its underlying portfolio structure is meaningfully different.
While both funds are grouped as Foreign Small/Mid Growth, TOVYX maintains:
|
Metric |
TOVYX |
BCSVX |
|---|---|---|
|
Primary Focus |
Mid/large cap stability |
Micro/small cap growth |
|
Star Rating (May 2026) |
5 stars |
2 stars |
When Morningstar puts BCSVX and TOVYX in the same bucket, it ignores the market cap mismatch and creates an apples-to-oranges comparison.
In a volatile market, TOVYX’s large-cap anchor helps it outperform, earning it more stars. Meanwhile, a fund like BCSVX—which stays true to its small/micro-cap mission—gets penalized with 2 stars simply because its specific asset class is out of favor. The star rating isn't telling you which manager is better; it's often just telling you which size of company has performed better lately.
At Global View, we don't look at the stars; we look at the DNA of the fund and the professionals who operate it. We analyze style drift, market cap exposure, and concentration risk to ensure your portfolio is built for the next market cycle, not the last one.
Are you choosing funds because of their current backward-looking ratings or because of their future potential? Let’s look under the hood together. Schedule a complimentary Fund DNA Review with a Global View advisor to audit your portfolio's hidden risks.
Disclaimer: Past performance is no guarantee of future results. Information regarding BCSVX and TOVYX is based on data available as of May 2026. For personalized investment strategies, consult with a Global View advisor.